1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Comparison of study variables for seizure freedom (n = 188)
Variable Seizure-Free (n = 124) Persistent (n = 64) P Value
Age at surgery (mean) (yr) 18.68 ± 11.43 14.66 ± 10.50 .020
Age of onset (mean) (yr) 8.45 ± 8.18 6.91 ± 6.09 .198
Duration of epilepsy (mean) (%) 10.72 ± 7.31 7.90 ± 6.56 .012
Women (%) 56 (45.2%) 36 (56.3%) .168
Febrile convulsions (%) 15 (12.1%) 8 (12.7%) 1.000
Multiple types of seizures (%) 21 (16.9%) 31 (48.4%) <.001
Delayed development (%) 23 (18.5%) 24 (37.5%) .007
Daily seizures (%) 63 (50.8%) 43 (67.2%) .043
Presence of aura (%) 35 (28.2%) 8 (12.5%) .017
Regional spikes on interictal EEG (%) 66 (54.1%) 27 (42.2%) .168
Regional ictal EEG onset pattern (%) 62 (50.0%) 26 (46.2%) .280
Clear-cut FCD on MRI (%) 94 (75.8%) 42 (65.6%) .169
Focal FDG-PET pattern (%) 97 (78.2%) 47 (73.4%) .472
Focal ictal SPECT pattern (%) 51 (71.8%) 26 (66.7%) .664
Eloquent cortex location (%) 16 (12.9%) 20 (31.3%) .003
FCD type I (%) 57 (47.5%) 45 (73.8%) .001
FCD type II (%) 63 (52.5%) 16 (26.2%) .001
FCD type I and II (%) 4 (3.2%) 3 (4.6%) .691
Acute postoperative seizures (%) 32 (25.8%) 32 (50.0%) .001
Complete resection (%) 105 (96.3%) 28 (54.9%) <.001